ATE285795T1 - Polypropylenbasierte behälter für prostaglandin- enthaltende produkte - Google Patents

Polypropylenbasierte behälter für prostaglandin- enthaltende produkte

Info

Publication number
ATE285795T1
ATE285795T1 AT99931790T AT99931790T ATE285795T1 AT E285795 T1 ATE285795 T1 AT E285795T1 AT 99931790 T AT99931790 T AT 99931790T AT 99931790 T AT99931790 T AT 99931790T AT E285795 T1 ATE285795 T1 AT E285795T1
Authority
AT
Austria
Prior art keywords
containing products
polypropylene based
based containers
prostaglandin containing
prostaglandin
Prior art date
Application number
AT99931790T
Other languages
German (de)
English (en)
Inventor
Alan L Weiner
Subhash C Airy
Cody Yarborough
Julia A Clifford
William E Mccune
Original Assignee
Alcon Mfg Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22235155&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE285795(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alcon Mfg Ltd filed Critical Alcon Mfg Ltd
Application granted granted Critical
Publication of ATE285795T1 publication Critical patent/ATE285795T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
AT99931790T 1998-07-14 1999-06-15 Polypropylenbasierte behälter für prostaglandin- enthaltende produkte ATE285795T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9278698P 1998-07-14 1998-07-14
PCT/US1999/013276 WO2000003736A1 (en) 1998-07-14 1999-06-15 Prostaglandin product

Publications (1)

Publication Number Publication Date
ATE285795T1 true ATE285795T1 (de) 2005-01-15

Family

ID=22235155

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99931790T ATE285795T1 (de) 1998-07-14 1999-06-15 Polypropylenbasierte behälter für prostaglandin- enthaltende produkte

Country Status (15)

Country Link
EP (1) EP1011728B1 (https=)
JP (2) JP2002520368A (https=)
KR (1) KR20010021835A (https=)
CN (1) CN1146423C (https=)
AR (1) AR019773A1 (https=)
AT (1) ATE285795T1 (https=)
AU (1) AU743607B2 (https=)
BR (1) BR9906597A (https=)
CA (1) CA2295512C (https=)
DE (1) DE69922916T2 (https=)
ES (1) ES2234270T3 (https=)
PT (1) PT1011728E (https=)
TW (1) TW585769B (https=)
WO (1) WO2000003736A1 (https=)
ZA (1) ZA997794B (https=)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000003736A1 (en) * 1998-07-14 2000-01-27 Alcon Laboratories, Inc. Prostaglandin product
JP4834224B2 (ja) 1999-03-05 2011-12-14 デューク ユニバーシティ Ｃ１６不飽和ｆｐ−選択的プロスタグランジン類縁体
US6894175B1 (en) 1999-08-04 2005-05-17 The Procter & Gamble Company 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use
JP4563636B2 (ja) * 1999-09-10 2010-10-13 大正製薬株式会社 プロスタグランジン誘導体
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
CA2422031C (en) * 2000-09-13 2011-11-15 Santen Pharmaceutical Co., Ltd. Ophthalmic solutions comprising difluoroprostaglandin f2 alpha
WO2002022106A2 (en) * 2000-09-14 2002-03-21 Novartis Ag Stable ophthalmic preparation
EP1486192A4 (en) * 2002-03-18 2010-07-14 Santen Pharmaceutical Co Ltd HIGH-TEMPERATURE-STERILIZABLE INSTILLER
DK1532981T3 (da) * 2002-08-23 2008-01-28 Santen Pharmaceutical Co Ltd Stabile öjendråber, der indeholder latanoprost som den aktive bestanddel
WO2005011704A1 (ja) * 2003-07-31 2005-02-10 Santen Pharmaceutical Co., Ltd. プロスタグランジン含有製品
CN102526064A (zh) * 2004-12-09 2012-07-04 参天制药株式会社 含有分子内具有氟原子的前列腺素的制品
JP4753178B2 (ja) * 2004-12-24 2011-08-24 参天製薬株式会社 プロスタグランジンＦ２α誘導体含有製品
WO2006068266A1 (ja) * 2004-12-24 2006-06-29 Santen Pharmaceutical Co., Ltd. プロスタグランジンＦ２ａ誘導体含有製品
JP5252787B2 (ja) * 2005-08-02 2013-07-31 参天製薬株式会社 熱的に不安定な薬物の分解抑制方法
EP1916002B1 (en) * 2005-08-02 2014-03-05 Santen Pharmaceutical Co., Ltd. Method for prevention of degradation of thermally unstable substance
CN101400354B (zh) * 2006-03-13 2014-10-22 株式会社·R-技术上野 水性组合物
CN105566192B (zh) * 2006-10-02 2019-01-22 于崇曦 具有快速皮肤穿透速度的带正电荷的水溶性的前列腺素及相关化合物的前药
US8455513B2 (en) 2007-01-10 2013-06-04 Aerie Pharmaceuticals, Inc. 6-aminoisoquinoline compounds
WO2008096804A1 (ja) 2007-02-07 2008-08-14 Teika Pharmaceutical Co., Ltd. ラタノプロスト含有点眼剤
EP2193795B1 (en) * 2007-08-29 2014-10-01 Wakamoto Pharmaceutical Co., Ltd. Latanoprost-containing aqueous pharmaceutical composition
WO2009084021A2 (en) * 2007-10-16 2009-07-09 Sun Pharma Advanced Research Company Limited Novel ophthalmic compositions
TWI544927B (zh) * 2008-03-17 2016-08-11 愛爾康研究有限公司 具有低濃度的表面活性劑以促進治療劑之生物可利用性的藥學組成物
JP2009256281A (ja) * 2008-04-21 2009-11-05 Teika Seiyaku Kk イソプロピルウノプロストン含有点眼剤組成物
EP2127638A1 (en) * 2008-05-30 2009-12-02 Santen Pharmaceutical Co., Ltd Method and composition for treating ocular hypertension and glaucoma
US8450344B2 (en) 2008-07-25 2013-05-28 Aerie Pharmaceuticals, Inc. Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
US20100087540A1 (en) * 2008-10-07 2010-04-08 R-Tech Ueno, Ltd. Pharmaceutical composition
CA2749352A1 (en) * 2009-02-20 2010-09-10 Micro Labs Limited Storage stable prostaglandin product
EP3053913B1 (en) 2009-05-01 2018-03-07 Aerie Pharmaceuticals, Inc. Dual mechanism inhibitors for the treatment of disease
DE102009021372A1 (de) * 2009-05-14 2010-11-18 Ursapharm Arzneimittel Gmbh Phosphatfreie pharmazeutische Zusammensetzung zur Glaukombehandlung
WO2011027778A1 (ja) * 2009-09-01 2011-03-10 株式会社アールテック・ウエノ 高眼圧症および緑内障処置のための眼局所投与用組成物
EP2478906A4 (en) 2009-09-17 2013-02-20 Senju Pharma Co AQUEOUS OPHTHALMIC DROPS THAT CONTAIN LATANOPROST, AND A METHOD OF INHIBITING ADSORPTION OF LATANOPROST ON A RESIN
US8658676B2 (en) 2010-10-12 2014-02-25 The Medicines Company Clevidipine emulsion formulations containing antimicrobial agents
EP2627173B2 (en) * 2010-10-12 2018-07-04 Chiesi Farmaceutici S.p.A. Clevidipine emulsion formulations containing antimicrobial agents
EP2452669A1 (en) 2010-10-29 2012-05-16 Omnivision GmbH Ophthalmic composition
EP2567689A1 (en) 2011-09-12 2013-03-13 Visiotact Pharma Ophthtalmic compositions comprising prostaglandin F2 alpha derivatives and hyaluronic acid
DK3811943T3 (da) 2013-03-15 2023-04-03 Aerie Pharmaceuticals Inc Forbindelse til anvendelse til behandling af øjenlidelser
ES2953346T3 (es) * 2014-01-10 2023-11-10 Santen Pharmaceutical Co Ltd Composición farmacéutica que contiene un compuesto de ácido piridilaminoacético y aceite de ricino polioxietilenado
BR112016015909B1 (pt) 2014-01-10 2020-09-29 Santen Pharmaceutical Co., Ltd. Composição farmacêutica contendo composto de ácido piridilaminoacético
JP5951921B1 (ja) * 2014-12-12 2016-07-13 興和株式会社 組成物
US9643927B1 (en) 2015-11-17 2017-05-09 Aerie Pharmaceuticals, Inc. Process for the preparation of kinase inhibitors and intermediates thereof
KR102568079B1 (ko) * 2016-08-31 2023-08-17 에어리 파마슈티컬즈, 인코포레이티드 안과용 조성물
KR20190135027A (ko) 2017-03-31 2019-12-05 에어리 파마슈티컬즈, 인코포레이티드 아릴 시클로프로필-아미노-이소퀴놀리닐 아미드 화합물
AU2019337703B2 (en) 2018-09-14 2023-02-02 Aerie Pharmaceuticals, Inc. Aryl cyclopropyl-amino-isoquinolinyl amide compounds
KR102756146B1 (ko) * 2019-06-28 2025-01-17 한미약품 주식회사 저장 안정성이 개선된 라타노프로스트 함유 점안제

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3785602T2 (de) * 1986-03-13 1993-09-02 Univ Columbia Verwendung von a-, b- und c-prostaglandinen und deren derivaten zur behandlung von augen-hypertension und glaukom.
JPS62292719A (ja) * 1986-06-12 1987-12-19 Kaken Pharmaceut Co Ltd 外用澄明水溶性製剤
ZA88963B (en) * 1987-02-27 1989-11-29 Allergan Inc Prostaglandins useful for lowering intraocular pressure
JPH0228112A (ja) * 1988-04-21 1990-01-30 Kaken Pharmaceut Co Ltd 点眼用眼圧調整剤
JP3256997B2 (ja) * 1990-08-30 2002-02-18 千寿製薬株式会社 安定な水性製剤
US5425480A (en) * 1992-12-17 1995-06-20 Ryder International Corporation Dose dispenser having a molded plastic housing with a cavity and a metallic foil wall covering the cavity
US5631287A (en) * 1994-12-22 1997-05-20 Alcon Laboratories, Inc. Storage-stable prostaglandin compositions
JPH09124484A (ja) * 1995-10-27 1997-05-13 Schering Purau Kk 点眼剤
JPH10101863A (ja) * 1996-09-30 1998-04-21 Nippon Zeon Co Ltd 成形材料
WO2000003736A1 (en) * 1998-07-14 2000-01-27 Alcon Laboratories, Inc. Prostaglandin product

Also Published As

Publication number Publication date
AU743607B2 (en) 2002-01-31
HK1028563A1 (en) 2001-02-23
JP2002520368A (ja) 2002-07-09
ZA997794B (en) 2001-01-02
KR20010021835A (ko) 2001-03-15
CN1146423C (zh) 2004-04-21
ES2234270T3 (es) 2005-06-16
CA2295512C (en) 2009-05-26
DE69922916T2 (de) 2005-06-09
DE69922916D1 (de) 2005-02-03
EP1011728B1 (en) 2004-12-29
BR9906597A (pt) 2000-07-18
JP2010100652A (ja) 2010-05-06
CA2295512A1 (en) 2000-01-14
EP1011728A1 (en) 2000-06-28
WO2000003736A1 (en) 2000-01-27
TW585769B (en) 2004-05-01
AU4822099A (en) 2000-02-07
CN1272063A (zh) 2000-11-01
PT1011728E (pt) 2005-03-31
AR019773A1 (es) 2002-03-13

Similar Documents

Publication Publication Date Title
DE69922916D1 (de) Polypropylenbasierte behälter für prostaglandin-enthaltende produkte
ATE260593T1 (de) Belüfteter behälter für produkte
DE69811232D1 (de) Behälter für anaerobe produkte
DE69935730D1 (de) Indikator für aerosolcontainer
ATE303953T1 (de) Stapelbare kästen für flaschen niedriger tiefe
DE60036630D1 (de) Behälter für kosmetische produkte
DE69710626D1 (de) Verbesserungen für Behälter
DE69928378D1 (de) Geruchsverstärkende zusammensetzung für kosmetische produkte
DE69942308D1 (de) Abgabesystem für artikel
IT1304321B1 (it) Mezzi contenitori
DE69916323D1 (de) Verpackungsbehälter
ITMI941394A0 (it) Etichetta per confezioni richiudibili
DE69926732T2 (de) Abnehmbarer verschluss für kunststoffbehälter
DE69927081D1 (de) Schachtel für Tabakprodukte
PT966952E (pt) Produtos liquidos contendo eritritol
DE69505453D1 (de) Verpackung für Behälter
DE69809441D1 (de) Verpackungsschachtel für nahrungsmitteln
DE69615625D1 (de) Zusammengesetzte verpackung für auslöffelbare produkte
DE69610246D1 (de) Behälter für Platten
NO20004543D0 (no) Beholder for jordbruksprodukter
DE69635923D1 (de) Schnappverschluss für bierfass
ATE267747T1 (de) Verschluss für behälter flüssiger produkte
DE69812719D1 (de) Stützrahmen für verpackungsbehälter
DE69600932D1 (de) Schauverpackung für Artikel
DE19780218D2 (de) Verpackung für plattenförmigen Informationsträger

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1011728

Country of ref document: EP